News & Updates

Serum uric acid (SUA) is significantly associated with all-cause and cardiovascular (CV) mortality in older adults, with substantial age-related differences, reports a study. The risk of death increases with higher SUA levels in individuals aged 65‒74 years, with a prognostic threshold of 4.8 mg/dl.

Lower diastolic blood pressure (DBP) appears to independently contribute to a higher risk of in-hospital major adverse cardiovascular events (MACE) and follow-up all-cause mortality, suggests a recent study.

Intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) significantly improves survival in patients with acute myocardial infarction (AMI), a recent study has found.

The use of a novel compression device helps reduce the incidence of pocket haematomas and skin erosions in patients undergoing cardiovascular electronic implantable device (CIED) implantation, according to a recent study.

The investigational antisense medicine pelacarsen substantially reduces direct lipoprotein(a) cholesterol (Lp[a]-C) and delivers neutral-to-mild lowering of low-density lipoprotein cholesterol (LDL-C) corrected for its Lp(a)-C content (LDL-Ccorr), reports a study.

Older patients undergoing subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation have a comparable risk of death, device reoperation, device removal for infection, device reoperation without infection, and cardiovascular and all-cause readmission with those receiving transvenous ICD (TV-ICD), a study has shown.